PRODIGY PHARMA
Live / Applied — Suspended — suspension check completed, case still suspended (as of 26 Jan 2026)
What this means for you
Not registered yet, but its 28 Aug 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98720939
- Mark type
- Stylized text
- Filed
- 28 Aug 2024
- Attorney of record
- Timothy C. Bradley
Goods and services
- Class 035 — Advertising and business services: Marketing services; providing advertising, marketing, and promotional services for the pharmaceutical and medical industry; marketing of telemedicine pharmaceutical preparations to be distributed via compounding pharmacies
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines not containing or derived from cannabis with a delta-9 THC concentration of more than 0.3 percent on a dry weight basis
- Class 044 — Medical, beauty and agricultural services: Pharmaceutical compounding services not featuring substances containing or derived from cannabis with a delta-9 THC concentration of more than 0.3 percent on a dry weight basis; production of cannabinoid-based pharmaceutical ingredients
Owner
- Prodigy Biopharma LLC, Miami, FL, US
Prosecution history
- 26 Jan 2026 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 25 Jul 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 25 Jul 2025 — LETTER OF SUSPENSION E-MAILED
- 25 Jul 2025 — SUSPENSION LETTER WRITTEN
- 01 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Apr 2025 — NON-FINAL ACTION E-MAILED
- 02 Apr 2025 — NON-FINAL ACTION WRITTEN
- 25 Mar 2025 — ASSIGNED TO EXAMINER
- 25 Mar 2025 — ASSIGNED TO EXAMINER
- 04 Mar 2025 — ASSIGNED TO EXAMINER
- 17 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Aug 2024 — NEW APPLICATION ENTERED